Almost a decade in the making, the human protein map is now available thanks to a joint effort, involving over 80 researchers.

A recent study strongly suggests that the protein GPR56 is involved in the biology of depression, which could offer a novel target for new antidepressant drugs.

A pilot study suggests the feasibility of convalescent plasma (CP) therapy for treating COVID-19 patients. No specific antiviral treatments exist for SARS-CoV-2, the virus that causes COVID-19, creating a need for alternative treatment strategies.

Scientists describe a more efficient way to sequence individual cells and visualize the massive amount of data that ensues.

A team of researchers has used a protein called interleukin(IL)-27, which has shown promise in reducing tumor growth and helping stop cancer from spreading in the body.

Researchers have reported finding a substantial collection of genes for metabolic cycles — a defining characteristic of cellular life — in a wide range of “giant viruses.”

The spread of COVID-19 has caused huge changes in how society functions. Scientific research has been similarly changed. Whilst efforts to fight the virus have seen huge investment in vaccine research, diagnostics and efforts to understand how the virus spreads, other fields of research have largely ground to a halt. We spoke to five scientists about how the COVID-19 outbreak is affecting them.

Technology Networks is committed to keeping you updated with the latest research in this space. In this article, you'll find a curation of our latest COVID-19 vaccine-related content.

An increasing number of online platforms are enabling scientists to share their research before it has undergone peer-review. In this article, we explore the concept of preprints.